Sterling Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.7K Sell
775
-53
-6% -$3.61K ﹤0.01% 1527
2026
Q1
$53.5K Sell
828
-2
-0.2% -$141 ﹤0.01% 1608
2025
Q4
$55.9K Buy
830
+644
+346% +$43.3K ﹤0.01% 1758
2025
Q3
$13.6K Sell
186
-1
-0.5% -$66 ﹤0.01% 2328
2025
Q2
$9.73K Buy
187
+56
+43% +$3.19K ﹤0.01% 2146
2025
Q1
$8.36K Buy
131
+2
+2% +$116 ﹤0.01% 1925
2024
Q4
$6.17K Sell
129
-37,107
-100% -$1.9M ﹤0.01% 2361
2024
Q3
$2.13M Buy
+37,236
New +$2.13M 0.03% 373

Other funds holding HALO

Sterling Capital Management's HALO Position: Q2 2026 in Review

Sterling Capital Management reduced its Halozyme (HALO) stake by 6.4% in Q2 2026, selling an estimated $3.61K and leaving 775 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Sterling Capital Management first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.13M in Q3 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Sterling Capital Management held 775 shares of Halozyme worth $60.7K as of Q2 2026.
  • Sterling Capital Management sold 53 Halozyme shares in Q2 2026, an estimated $3.61K.
  • Halozyme made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1527 holding.
  • Sterling Capital Management first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Halozyme position peaked at $2.13M in Q3 2024.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.